In Brief
Tertiary lymphoid organs emerge during nonresolving inflammation. Habenicht and colleagues find that atherosclerosis immune responses are controlled by artery tertiary lymphoid organs in the adventitial connective tissue adjoining arteries. These lymphocyte aggregates arise through vascular smooth muscle cell lymphotoxin b receptor signaling and act as powerhouses of protective atherosclerosis immunity.
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SUMMARY
Tertiary lymphoid organs (TLOs) emerge during nonresolving peripheral inflammation, but their impact on disease progression remains unknown. We have found in aged Apoe À/À mice that artery TLOs (ATLOs) controlled highly territorialized aorta T cell responses. ATLOs promoted T cell recruitment, primed CD4 + T cells, generated CD4 + , CD8 + , T regulatory (Treg) effector and central memory cells, converted naive CD4 + T cells into induced Treg cells, and presented antigen by an unusual set of dendritic cells and B cells. Meanwhile, vascular smooth muscle cell lymphotoxin b receptors (VSMC-LTbRs) protected against atherosclerosis by maintaining structure, cellularity, and size of ATLOs though VSMC-LTbRs did not affect secondary lymphoid organs: Atherosclerosis was markedly exacerbated in Apoe À/À Ltbr À/À and to a similar extent in aged Apoe À/À Ltbr fl/fl Tagln-cre mice. These data support the conclusion that the immune system employs ATLOs to organize aorta T cell homeostasis during aging and that VSMC-LTbRs participate in atherosclerosis protection via ATLOs.
INTRODUCTION
A central tenet in immunology is that primary T cell responses are initiated in secondary lymphoid organs (SLOs) (Mackay, 1999; Mackay and von Andrian, 2001; Sallusto et al., 2004; Steinman, 2012; Woodland and Kohlmeier, 2009) . In contrast, roles of tertiary lymphoid organs (TLOs) have not yet been defined (Aloisi and Pujol-Borrell, 2006; Drayton et al., 2006; Moyron-Quiroz et al., 2004; Roozendaal and Mebius, 2011) . Although similarities between SLOs and TLOs are apparent, major differences deserve attention: SLOs form during ontogeny at predetermined locations, trigger priming of naive T cells following interaction with dendritic cells (DCs), and resume quiescence upon elimination of antigen (Miller et al., 2004) . In contrast, TLOs emerge as unencapsulated lymphoid aggregates in chronic inflammatory diseases at undetermined locations in adult organisms (Grä bner et al., 2009; Nathan and Ding, 2010; Weyand et al., 2001) . Though TLO neogenesis correlates with disease severity (Galkina et al., 2006; Galkina and Ley, 2009; Grä bner et al., 2009; Lopez-Diego and Weiner, 2008; Moyron-Quiroz et al., 2004) , their role has not been determined (Grä bner et al., 2009; Mohanta et al., 2014) .
We have observed that artery TLOs (ATLOs) emerge in the aorta adventitia adjacent to atherosclerotic plaques in Apoe À/À mice during aging and that their size and structure correlate with disease severity in a lymphotoxin b receptor (LTbR)-dependent way (Grä bner et al., 2009; Moos et al., 2005; Zhao et al., 2004) . We have also noticed that vascular smooth muscle cells (VSMCs) of abdominal aorta segments that are located between atherosclerotic plaques and ATLOs express the lymphorganogenic cytokines, i.e., CCL21 and CXCL13 (Grä bner et al., 2009) , that VSMCs express LTbRs in vivo, and that LTbR signaling initiates transdifferentiation of VSMCs to a lymphoid tissue organizer-like phenotype in vitro (Lö tzer et al., 2010) . These results are consistent with the view that media VSMC-LTbRs transduce plaque-derived inflammatory cues to the adventitia to promote ATLO neogenesis (Aloisi and PujolBorrell, 2006; Drayton et al., 2006; Gebhardt et al., 2011; Geginat et al., 2001; Glass and Witztum, 2001; Grä bner et al., 2009; Groom and Luster, 2011; Hammerschmidt et al., 2008; Hansson and Hermansson, 2011; Lichtman et al., 2013; Mohanta et al., 2014; Moyron-Quiroz et al., 2004; Nathan and Ding, 2010; Roozendaal and Mebius, 2011; Weber and Noels, 2011) . In the present study, we explored the impact of ATLOs on atherosclerosis T cell responses and asked whether VSMC-LTbRs might participate in disease progression. Our data reveal that the aging immune system employs ATLOs to control atherosclerosis T cell immunity and that VSMC-LTbRs maintain ATLO structure and attenuate atherosclerosis. S2A ). Again, aging-associated changes remained identical in Apoe À/À versus WT mice. These data revealed large aging-associated changes in T cell subtype composition and activation, which was identical in Apoe À/À and WT mice (see also Linton and Dorshkind, 2004; Montecino-Rodriguez et al., 2013) . MIAME-compliant microarrays of Apoe À/À and WT spleens and blood (http://www.ncbi.nlm.nih.gov/geo/); deposited in the NCBI Gene Expression Omnibus (GEO); accession number GSE40156) revealed robust age-associated changes in total gene-expression profiles and in gene ontology (GO) terms related to immune and inflammatory responses but remained similar in Apoe À/À versus WT mice (Figures S2D and S2E; Table   S1 ) (C.Y. and A.J.R.H., unpublished data). Transcript profiles of WT aortas also showed age-associated changes ( Figure S1B ; Table S1 ). However, unlike SLOs and blood, aged Apoe À/À versus WT aortas indicated extensive changes in a large number of overlapping and newly expressed transcripts (Figures S1B, S2B, and S2C; Table S1 ). (Mackay, 1999; Mackay and von Andrian, 2001; Sallusto et al., 2004; Steinman, 2012; Woodland and Kohlmeier, 2009 ). Naive CD4 + T cells were rare in ATLOs ( Figure 2C ). Indeed, the large majority of ATLO CD4 + T cells were T EM cells yielding a 27-fold ratio of T EM versus naive cells ( Figure 2C ). Treg cells also had a T EM phenotype yielding an Table S1 (see also Figure S3 ). Figure 2C ). The composition of ATLO memory cells contrasted to that in SLOs and blood, which contained fewer T EM cells ( Figure 2C ). There was no systemic alteration in any memory T cell subtype in liver, lung, and other peripheral tissues between the mouse genotypes (data not shown). These data showed that T EM and T CM T cells dominate in ATLOs when compared to their SLO counterparts.
RESULTS
Systemic T Cell Aging in
ATLOs Educate Aorta T Cells
Tissue-specific homing and education of T EM and T CM cells is essential for long-term immunosurveillance in peripheral tissues. To achieve effective immunosurveillance, the immune system educates memory cells to express functionally relevant tissue homing molecules (Lathrop et al., 2011; Lathrop et al., 2008; Mackay, 1999; Mackay and von Andrian, 2001; Mikhak et al., 2013; Sallusto et al., 2004) . T cell tissue tropism has been studied in skin and intestine (Sheridan and Lefranç ois, 2011) , but little is known about atherosclerosis. We determined expression of prototypic homing and function-associated markers (Sheridan and Lefranç ois, 2011 Figure S4 ; data not shown).
When compared to SLOs, all ATLO T cell subtypes showed low expression of the chemokine receptors CXCR3, CCR4, and CCR7, as well as CD122, though comparably higher Tnfrsf18 (tumor necrosis factor receptor superfamily member 18; also referred to as glucocorticoid-induced tumor necrosis factor receptor-related gene, i.e., GITR; data not shown). Thus, all T cell subtypes and in particular ATLO Treg cells showed strong atherosclerosis education signatures. The magnitude of T cell education in atherosclerosis is further illustrated by comparing ATLO Treg cell phenotypes with those in a mouse model of systemic multiorgan inflammation, i.e., Relb À/À mice (Weih et al., 1995) . Although Relb À/À spleen, lung, liver, and blood showed increased numbers of CD103
+ Treg cells, they fell short of those in ATLOs by a large margin ( Figure 2D ). Moreover, non-obese diabetic (NOD) mouse SLOs and pancreases (i.e., a model of autoimmune diabetes) did not reveal educated T cells (data not shown).
ATLOs Direct Naive CD4
+ and Naive CD8 + T Cell Homing by Enhanced Recruitment and Decreased Egress Recruitment of naive T cells in SLO-sufficient mice has not been studied in any TLO (Woodland and Kohlmeier, 2009 ). To demonstrate naive T cell recruitment by ATLOs, we had to consider two issues: naive T cells egress SLOs via efferent lymph vessel sphingosine 1-phosphate receptor type 1 (S1PR1), and the recirculation rate of naive T cells in SLOs is constitutively high. Consequently, the presence of T EM or T CM cells in SLOs or ATLOs cannot be taken as evidence for their local generation (Schwab and Cyster, 2007) . Hence, demonstration of participation of ATLOs in naive T cell recruitment in atherosclerosis requires that T cell recirculation had to be prevented. Application of the S1PR1 antagonist FTY720 in spleen-sufficient mice led to a reduction of blood T cells by >95% and increased numbers in SLOs, indicating that T cell recirculation was largely but not entirely prevented. As FTY720 is less effective in preventing spleen T cell egress, splenectomy was required in addition to FTY720 treatment. Thus, a combined splenectomy and FTY720-treatment approach was adopted (Matloubian et al., 2004) . In splenectomized and FTY720-treated mice, the total number of recruited naive CD4 + T cells was higher in Apoe À/À adventitiae, ATLOs, and in Apoe À/À and WT RLNs when compared to their untreated counterparts ( Figure 3A ). Furthermore, Apoe
aortas recruited >3 times more cells when compared to WT aortas and Apoe À/À abdominal aorta recruited markedly more naive CD4 + T cells when compared to the thoracic aorta (Figure 3A) . These data indicated that naive CD4 + T cell recirculation in both Apoe À/À and WT adventitiae is at least in part regulated by egress via S1PR1. However, Apoe À/À and WT RLNs recruited similar numbers of naive CD4 + cells within 24 hr ( Figure 3A ). We observed that S1pr1 mRNA expression was >40% lower in ATLOs when compared to ATLO-free abdominal aorta adventitia in the transcriptome atlas (data not shown). For naive CD8 + T cells, similar data were obtained (data not shown). When leukocyte recruitment was determined using multiphoton laser-scanning microscopy (MPLSM), ATLOs showed 10-fold homing rates when compared to WT aortas at 24 hr ( Figure 3A ). The first stages of naive T cell priming in SLOs, i.e., immigration and activation (see below), occur within 24 hr (Mempel et al., 2004; Miller et al., 2004) . To examine the long-term fate of naive CD4 + T cells, we transferred flow cytometry-purified Ly5.1 T cells into aged Ly5.2 Apoe À/À or WT mice and aortas and SLOs were analyzed after 3 weeks. Apoe À/À aortas retained >10-fold more T cells versus WT aortas ( Figure 3A , lower right panels). These data indicated that ATLOs have a large capacity to recruit naive T cells into the arterial wall and generate T EM cells ( Figure 3A ). In support of clonal expansion of ATLO T cells, we noticed large numbers of CD3 + Ki67 + T cells (data not shown). Apoe À/À RLNs and spleen also showed higher numbers of transferred naive CD4 + T cells after 3 weeks when compared to those in WT mice consistent with the possibility that ATLOs mediate priming and generation of T EM cells followed by their subsequent migration into SLOs (data not shown). Figure S4 ). (B) Leukocyte movement. 3D plots of leukocyte movement in ATLOs or WT adventitiae were generated from MPLSM by placing the starting point of each track at the origin of the axes (Movies S1 and S2). Scale bars represent 80 mm; Scale red axis represents 10 mm.
(C) Leukocyte motility. Parameters: length, track velocity, and displacement were determined by MPLSM in 78-to 85-week-old Apoe À/À (n = 8 mice) or WT (n = 11 mice) abdominal aorta adventitiae or in Apoe À/À (n = 9 mice) or WT (n = 9 mice) popliteal LNs (pLNs) as described in the Experimental Procedures. Two-tailed
Wilcoxon-Mann-Whitney test corrected for multiple testing (Bonferroni) was performed on mouse means. *p % 0.05, **p % 0.01, ***p % 0.001.
ATLO T Cells Acquire Movement Parameters
Resembling Those in LNs Naive T cell priming in SLOs (Miller et al., 2004; Schneider et al., 2006) requires specific migration characteristics in T cell areas to allow extended T cell-DC interactions. We used MPLSM (Maffia et al., 2007) to compare T cell movement in ATLOs with those in the WT adventitia and LNs (Miller et al., 2004) . Adoptively transferred CMTPX-labeled leukocytes were examined at 24 hr. Numerous cells were visible in ATLOs though few cells were detectable in WT adventitia ( Figure 3B ). Cell movement was greatly enhanced in ATLOs ( Figure 3B ), whereas cells in WT aortas were nearly motionless with cell movement confined to a radius of $10 mm (Figures 3B and 3C ; Movie S1). In contrast, cells moved rapidly in ATLOs and cells that migrated >100 mm were observed in each of 8 Apoe We examined whether Treg cells were similarly activated by ATLOs using GFP-Treg cells purified from spleens and LNs of transgenic Foxp3-DTR-GFP mice (Kim et al., 2007 Figure 2D ; data not shown). These data suggested that the majority of aorta-educated endogenous ATLO Treg cells (Figure 2D Figures 4D and 4E) . WT RLNs and spleens showed low naive CD4 + T cell conversion into iTreg cells ( Figure 4E ). The absolute number of iTreg cells was 38-fold higher in Apoe À/À when compared to WT aortas ( Figure 4E ).
ATLOs Show an Aberrant Composition of AntigenPresenting Cells
Intima DCs expand during atherogenesis in young cholesterol-fed Ldlr À/À mice (Choi et al., 2011; Figure 5C ).
ATLO APCs Present Exogenous Antigen In Vivo
Two models of in vivo antigen presentation were established. At 24 hr after transfer of transgenic OT-II CD4 + T cells followed by previous observations obtained by others in in vitro added T cells (Koltsova et al., 2012) (Figure 5D ; Movies S3 and S4). To determine which APC type(s) present antigen in ATLOs, we employed the Ea/Y-Ae system (Itano et al., 2003) Figure 5B ). In summary, these results suggest that mDCs followed by B cells, macrophages, cDCs, and lyDCs are the major ATLO APCs.
The Immune System of VSMC-Ltbr -/-Mice Is
Indistinguishable from that of WT Mice
The role of TLOs in unresolvable inflammatory diseases remains unknown. Experimental approaches to unambiguously address this issue have not emerged (Aloisi and Pujol-Borrell, 2006; Mohanta et al., 2014; Pitzalis et al., 2014; Weyand et al., 2001 (Boucher et al., 2003; Lepore et al., 2005) ( Figure 6A ). Because controls for hyperlipidemic mice that lack LTbRs systemically and show multiple defects of their immune system (Fü tterer et al., 1998; Stopfer et al., 2004) , we also generated Apoe À/À Ltbr À/À mice ( Figure 6A ). Figure 6B , data not shown). We observed disruption of spleen structure, including a lack of germinal center (GC) B and marginal zone (MZ) B cells ( Figure 6C ), of spleen follicular dendritic cells (FDCs) ( Figure 6D ), of spleen marginal metallophilic macrophages ( Figure S6B ), and blood vessels of spleen white pulp ( Figure S6B ) though numbers of LN fibroblastic reticular cells (FRCs) ( Figure 6E ) and the composition of T cell subsets in spleen were comparable to those of WT mice ( Figure 6F ). However, compared to aged WT mice, Ltbr À/À mice showed increased ratios of T EM /naive splenic and blood T cell subsets ( Figures 6G and S6C mice revealed robust acceleration of atherosclerosis whose magnitude was indistinguishable from that of age-matched Apoe À/À Ltbr À/À mice ( Figure 7A ) and this acceleration was greater in the abdominal aorta when compared to other parts of the arterial tree ( Figure 7B ). These data indicate that VSMC-LTbRs maintain ATLO structure and cellularity and protect against atherosclerosis in a site-specific and age-dependent way.
Both
DISCUSSION
This study has identified ATLOs as the principal lymphoid tissue that controls atherosclerosis T cell responses during aging and suggests that VSMC-LTbRs protect against atherosclerosis by maintaining ATLO structure and cellularity. ATLO activities are selective and robust involving major steps of an antigen-specific primary T cell response: Recruitment of naive T cells, modulation of T cell motility toward characteristics of those in SLOs, activation of naive CD4
+ and naive CD8 + T cells, antigen presentation, generation of CD4 + , CD8 + , and
Treg memory cells, education of T EM and T CM cells, and conversion of naive CD4 + T cells into iTreg cells. Thus, the immune response in atherosclerosis is carried out in the adventitia during aging though it is assumed to be organized in plaques and/or in SLOs in young mice. Together with the systemic age-associated changes of all T cell compartments, these data suggest the paradigm that the senescent immune system is capable of selectively employing a TLO to organize unresolvable disease-specific immune responses. A fundamental unanswered question in the immunology of unresolving inflammation relates to the impacts of TLOs in any disease setting. Although there is correlative evidence that TLOs can afford disease protection in certain acute pathogen-triggered diseases and cancers (Aloisi and Pujol-Borrell, 2006; Drayton et al., 2006; Mohanta et al., 2014; Moyron-Quiroz et al., 2004; Pitzalis et al., 2014; Roozendaal and Mebius, 2011) , circumstantial evidence including clinical association studies has led investigators to assume that TLOs enforce rather than attenuate chronic inflammation and-in particular-autoimmune diseases (Aloisi and Pujol-Borrell, 2006; Pitzalis et al., 2014; Weyand et al., 2001) . Direct evidence for this proposition, however, would require blockade of TLO function without affecting the immune system systemically. This has not been a viable option in the past because molecules that specifically regulate TLO neogenesis in adult organisms as opposed to those that regulate SLO formation during ontogeny have not been identified (Drayton et al., 2006; Fü tterer et al., 1998; Roozendaal and Mebius, 2011 ). Yet, data reported here show that the structure and cellularity of a TLO can be altered without affecting SLOs. This was possible by targeting the LTbR of VSMCs using the late differentiation marker of these cells, i.e., SM22a/Transgelin (Boucher et al., 2003 (Roozendaal and Mebius, 2011) . The observation that Apoe
Ltbr fl/fl Tagln-cre mice showed disruption of ATLO structure and size supports the view that VSMCs can adopt lymphoid tissue organizer-like characteristics in advanced atherosclerosis.
Regarding the possible protection from atherosclerosis by ATLOs in aged mice, several aspects of our data merit attention: ATLOs generate both pro-inflammatory T EM and T CM cells and anti-inflammatory nTreg and iTreg cells (Ait-Oufella et al., 2006) . However, immunosuppressive leukocytes appear to restrict their effector counterparts under the pathogen-free conditions used in this study. Possibly, the highly activated ATLO nTreg and iTreg cells shift the balance between pro-atherogenic and anti-atherogenic T cell subtypes toward inhibition of immune responses by restricting activation in and the release of T EM and T CM cells from ATLOs. It will be a challenge for future studies to identify the specific roles of ATLO iTreg cells on atherosclerosis. Moreover, B cell subsets in ATLOs remain to be characterized In summary, these data define interactions between the aging/ senescent immune system, the media of aged arteries, and hyperlipidemia and characterize the role of abdominal aorta segments in generating highly territorialized ATLOs. ATLOs appear to function not only as powerhouses of advanced atherosclerosis immunity but also seemingly afford strong protection from advanced atherosclerosis in an age-and sitespecific way. These data raise the important possibility that TLOs in other forms of unresolvable inflammation also provide (B, upper panel) . Atherosclerotic lesions in different parts of the aorta were quantified as percentage of plaque areas (n = 3-6 mice per genotype (A, lower panels); plaque (P) sizes and ATLO sizes in different aorta segments were quantified as percentage of plaque areas, intima/media, and ATLO/media ratios, respectively (n = 5-10 sections in 3-8 mice per genotype) (B, lower panels). (C and D) Effect of Ltbr deletion on the ATLO structure. Histological and immunofluorescence stainings show ATLO cellularity (C) and HEV abundance (D) in abdominal aorta segments (n = 5-8 sections in n = 3-4 mice per genotype). Scale bar represents 2.5 mm (A); 100 mm (B); and 50 mm (C and D). Data represent means ± SEM; p values were determined by two-tailed Student's t test or by multiple testing (Bonferroni) using the GEE model as described in the Supplemental Experimental Procedures. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant, p > 0.05; nd, not detectable.
immunoprotection. Further studies are needed to identify mechanisms by which ATLO APCs and immune cell subtypes protect from atherosclerosis. Future studies should also help to isolate putative (auto)immune T and B cells and to uncover modes of peripheral tolerance breakdown during clinical stages of advanced atherosclerosis. This might facilitate identification of mechanisms underlying the poorly understood phenomenon of acute exacerbations and relapses in atherosclerosis and autoimmune diseases. A better understanding of ATLO immunity might thus be of major clinical significance as TLO-directed therapies are being evaluated for the treatment of chronic inflammatory diseases, autoimmune diseases, and cancer (Aloisi and PujolBorrell, 2006; Mohanta et al., 2014; Pitzalis et al., 2014; Weyand et al., 2001 CD11c-YFP and OT-II mice were bred at the Research Facility at the University of Glasgow. Mice were fed a standard rodent chow and kept under pathogen-free conditions. Animal procedures were conducted according to guidelines of the local Animal Use and Care Committees and the National Animal Welfare Laws.
Preparation of Single Cell Suspensions from Aorta, Spleen, LN, and Blood Cell suspensions from aorta was prepared by enzyme digestion as previously described with minor modifications and detailed in the Supplemental Experimental Procedures (Grä bner et al., 2009 ).
Cell Purification and Adoptive Transfers
Lymphocytes from SLOs were isolated from donor mice and injected into recipient mice, whereas for MPLSM studies, leukocyte cell suspensions and transgenic CD4 + T cells were prepared from SLOs of WT and OT-II mice, respectively, and i.v. injected as described in the Supplemental Experimental Procedures.
Flow Cytometry
Cells for flow cytometry were pretreated with purified anti-mouse CD16/ 32 mAb to block Fc receptors as described (Grä bner et al., 2009) . Cells were incubated with Abs for 25 min at 4 C, washed twice, and, when required, incubated with secondary mAbs or streptavidin conjugates for 20 min. After washing, 8-color flow cytometry measurements were performed on a FACSCanto II TM (BD Bioscience), and data were analyzed using FlowJo (Tree Star). Antibodies are described in the Supplemental Experimental Procedures.
Histology, Immunofluorescence, and Morphometry Tissues were prepared and stored as described (Grä bner et al., 2009 ). 10 mm cross-sections were prepared and every 10 th serial section at 100 mm intervals was stained with Oil Red O/hematoxylin to delineate ATLOs. Immunofluorescence staining was performed as previously described (Grä bner et al., 2009 ), using marker antibodies as described in online methods. DAPI was used to stain DNA. Secondary antibodies were used as previously described (Zhao et al., 2004) . For 3D imaging, z stacks were prepared at 0.3 mm intervals using a Plan Apochromatic 633 differential interference contrast (DIC) oil objective (NA1.4) with a scan zoom factor 3.1 and then processed with Zen 2009 Light Edition (Zeiss) and further processed as described in the Supplemental Experimental Procedures.
Atherosclerotic Lesion Analyses
Aortas were prepared, stained with Sudan-IV for en face atherosclerosis analysis, and the extent of atherosclerosis was assessed in total aorta, aortic arch, descending aorta, and abdominal aorta using ImageJ software as described (Cao et al., 2009; Schmitt et al., 2014) . The extent of atherosclerosis was assessed in total aorta, aortic arch, descending aorta, and abdominal aorta using ImageJ software as described in the Supplemental Experimental Procedures. In addition, plaque size and corresponding ATLO size were quantified in Oil red O/hematoxylin stained serial sections of the innominate artery and the abdominal aorta below the renal artery at 100 mm intervals as described (Grä bner et al., 2009 ).
Cell Culture
Aortic VSMCs and ECs were harvested from aortas of 10-to 12-week-old mice as described (Grä bner et al., 2009 ) and detailed in the Supplemental Experimental Procedures.
Administration of Ea Antigen
To study the ability of APCs to present systemic antigen, the Ea-GFP/Y-Ae system was used as previously described (Itano et al., 2003) . Briefly, aged Apoe À/À mice were i.v. injected either with 1 mg of Ea antigen or PBS, and assays were performed 4 hr later. 
LCM and Generation of Microarrays
Statistical Analyses
To compare flow cytometry data or morphometry data of multiple mouse groups, we used the generalized estimating equation model (GEE) as described in the Supplemental Experimental Procedures.
